Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males.
Adolescent
Condoms
/ statistics & numerical data
HIV Infections
/ prevention & control
Health Knowledge, Attitudes, Practice
Homosexuality, Male
/ psychology
Humans
Male
Patient Acceptance of Health Care
/ psychology
Pre-Exposure Prophylaxis
/ statistics & numerical data
Sexual and Gender Minorities
/ psychology
United States
/ epidemiology
Adolescents
Awareness
Human immunodeficiency virus (HIV)
Perceived efficacy
Pre-exposure prophylaxis (PrEP)
Willingness
Journal
Journal of urban health : bulletin of the New York Academy of Medicine
ISSN: 1468-2869
Titre abrégé: J Urban Health
Pays: United States
ID NLM: 9809909
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
14
8
2020
medline:
16
3
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Despite the approval of PrEP for adolescents by the FDA in 2018, little is known about the awareness and attitudes about PrEP use among adolescent sexual minority males, who are at the greatest risk for HIV. We analyzed baseline data from the MyPEEPS Mobile study, a multi-site randomized controlled trial evaluating the effectiveness of a mobile behavioral HIV prevention intervention. A substantial proportion (68.2%) of study participants (ages 13-18) had previously heard about PrEP, and an overwhelming majority (90.8%) reported willingness to take PrEP, to prevent HIV. On the other hand, only about one third (34.6%) of participants indicated that taking a daily HIV pill would be "very" or "completely" effective in preventing HIV when having sex without a condom. These findings suggest that high awareness and willingness to use PrEP across various adolescent subgroups present opportunities for increased PrEP advocacy among this young age group.
Identifiants
pubmed: 32789625
doi: 10.1007/s11524-020-00447-5
pii: 10.1007/s11524-020-00447-5
pmc: PMC7560632
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
749-757Subventions
Organisme : NINR NIH HHS
ID : K24 NR018621
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIMHD NIH HHS
ID : U01 MD011279
Pays : United States
Organisme : NINR NIH HHS
ID : K24NR018621
Pays : United States
Références
BMC Public Health. 2020 Jan 15;20(1):65
pubmed: 31941475
AIDS Behav. 2019 Jul;23(7):1974-1983
pubmed: 30697639
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):340-8
pubmed: 24784763
J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3:S375-S382
pubmed: 28604442
AIDS Behav. 2017 May;21(5):1268-1277
pubmed: 27873081
Sci Transl Med. 2012 Sep 12;4(151):151ra125
pubmed: 22972843
Soc Sci Med. 2017 Jan;172:115-123
pubmed: 27866750
Lancet HIV. 2019 Feb;6(2):e137-e140
pubmed: 30660592
AIDS. 2018 Nov 13;32(17):2633-2635
pubmed: 30096073
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
AIDS Educ Prev. 2019 Feb;31(1):63-81
pubmed: 30742477
AIDS Behav. 2015 Dec;19(12):2234-44
pubmed: 25735243
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5
pubmed: 26606148
AIDS Behav. 2018 Apr;22(4):1063-1074
pubmed: 28176168
BMJ Open. 2020 Jan 8;10(1):e028508
pubmed: 31919122
JMIR Public Health Surveill. 2018 Jan 23;4(1):e13
pubmed: 29362213
AIDS Educ Prev. 2018 Dec;30(6):449-462
pubmed: 30966769
AIDS Behav. 2017 May;21(5):1288-1298
pubmed: 27401537
AIDS Patient Care STDS. 2017 Dec;31(12):517-527
pubmed: 29211513
Curr HIV Res. 2013 Oct;11(7):520-7
pubmed: 24476355
Am J Prev Med. 2013 Jan;44(1 Suppl 2):S119-24
pubmed: 23253751
N C Med J. 2019 Jan-Feb;80(1):7-11
pubmed: 30622197